This is a bonus episode of the audio of a Breastcancer.org ⁠⁠⁠⁠webinar⁠⁠⁠⁠.

Triple-negative breast cancer (TNBC) is an invasive subtype of breast cancer that can be harder to treat and is more likely to come back. But new research into understanding TNBC is helping some patients find more precise treatment options. 

Learn about innovations in immunotherapy, genetic testing, and targeted therapies, why TNBC is different compared to other types of breast cancer, and what gives doctors hope about the future of care for people with TNBC.

You’ll also hear from two inspiring breast cancer advocates who created TNBC resources for patients after their own diagnosis.

Read more about triple-negative breast cancer.

Featured Speakers:

Maimah Karmo
Breast Cancer Advocate and Founder, Tigerlily

Roberto Leon-Ferre, MD
Co-Leader of the Triple-Negative Breast Cancer Working Group and Associate Professor at Mayo Clinic

Evelyn Taiwo, MD
Hematology and Oncology at New York Presbyterian Brooklyn Methodist Hospital and Associate Professor at Cornell University

Kelly Thomas
Breast Cancer Advocate and Founder, TNBC Thrivers

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org